Derma-Smoothe Scalp FS
"The US Food and Drug Administration (FDA) has approved a foam containing calcipotriene and betamethasone dipropionate (Enstilar, Leo Pharma Inc) for topical treatment of plaque psoriasis in adults 18 years of age and older, according to a "...
Topically applied Derma-Smoothe/FS® can be absorbed in sufficient amounts to produce systemic effects (see PRECAUTIONS).
Derma-Smoothe/FS® is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
This product contains refined peanut oil NF (see PRECAUTIONS section).This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 6/12/2012
Additional Derma-Smoothe Scalp/FS Information
Derma-Smoothe Scalp/FS - User Reviews
Derma-Smoothe Scalp/FS User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.